Literature DB >> 7804732

Venous thrombogenesis.

D Thomas1.   

Abstract

Venous thrombosis develops when stasis in the deep veins of the legs occurs at times of increased coagulability of the blood. This combination leads to the local generation of thrombin, which is the crucial event in the pathogenesis of this disease. Impaired fibrinolysis allows a small platelet-fibrin nidus to grow into an occluding thrombus. Demonstrable damage to the vessel wall does not appear to play a major role in the development of most cases of venous thrombosis. While the biochemical definition of hypercoagulability remains elusive, immunoregulatory cytokines have been shown to impair the normal non-thrombogenicity of the endothelial wall. This leads to local expression of procoagulant activity and resultant fibrin deposition. In the presence of stasis, the stage is then set for the development of clinically significant thrombi. Although hereditary absence of natural anticoagulants has been found in many patients with venous thrombosis, most patients have no detectable abnormality of their blood.

Entities:  

Mesh:

Year:  1994        PMID: 7804732     DOI: 10.1093/oxfordjournals.bmb.a072927

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  3 in total

1.  Deep upper limb and jugular venous thrombosis in dilated cardiomyopathy.

Authors:  P Venugopalan; A K Meharali; A K Agarwal
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

2.  Critically ill cancer patients are not consistently hypercoagulable after craniotomy.

Authors:  Joseph L Nates; Natarajan Aravindan; Cheryl Hirsch-Ginsberg; Kurt C Sizer; Spencer Kee; Anh T Nguyen; Karen Chen; Andrew D Shaw; Kristen J Price
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 3.  Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.

Authors:  Prakash Saha; Julia Humphries; Bijan Modarai; Katherine Mattock; Matthew Waltham; Colin E Evans; Anwar Ahmad; Ashish S Patel; Sobath Premaratne; Oliver T A Lyons; Alberto Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.